| Download ( PDF | 267kB) Nur für Mitarbeiter des Archivs |
Reverse diastolic intrarenal flow due to calcineurin inhibitor (CNI) toxicity
Böger, Carsten A., Rümmele, Petra, Mihatsch, Michael J., Banas, Bernhard und Krämer, Bernhard K. (2006) Reverse diastolic intrarenal flow due to calcineurin inhibitor (CNI) toxicity. American journal of transplantation 6 (8), S. 1963-1967.Veröffentlichungsdatum dieses Volltextes: 05 Aug 2009 13:27
Artikel
DOI zum Zitieren dieses Dokuments: 10.5283/epub.1316
Zusammenfassung
Renal calcineurin inhibitor (CNI) toxicity is a frequent side effect of immunosuppression with CNIs in solid organ transplantation, leading to acute and chronic renal failure. Acute CNI toxicity is due to vasoconstriction of the vasa afferens and efferens and vacuolization of smooth muscle cells with medial hyalinosis, leading to vessel lumen narrowing. Our case had an acute renal failure 8 ...
Renal calcineurin inhibitor (CNI) toxicity is a frequent side effect of immunosuppression with CNIs in solid organ transplantation, leading to acute and chronic renal failure. Acute CNI toxicity is due to vasoconstriction of the vasa afferens and efferens and vacuolization of smooth muscle cells with medial hyalinosis, leading to vessel lumen narrowing. Our case had an acute renal failure 8 months after deceased donor kidney transplantation under treatment with tacrolimus, sirolimus and prednisolone. In Doppler sonography, we observed reverse diastolic intrarenal blood flow, reflecting intense vessel narrowing. There were histological signs of acute CNI toxicity. Within days of reducing the tacrolimus trough level, renal function improved markedly and Doppler sonography showed orthograde intrarenal blood flow. This is the first case of functional, Doppler sonographic evidence for CNI-induced, rapidly reversible narrowing of intrarenal vessels. This case illustrates the potential role of tacrolimus and sirolimus dosing in combination therapy to produce severe intrarenal vasoconstriction.
Alternative Links zum Volltext
Beteiligte Einrichtungen
Details
| Dokumentenart | Artikel | ||||||
| Titel eines Journals oder einer Zeitschrift | American journal of transplantation | ||||||
| Verlag: | BLACKWELL PUBLISHING | ||||||
|---|---|---|---|---|---|---|---|
| Ort der Veröffentlichung: | OXFORD | ||||||
| Band: | 6 | ||||||
| Nummer des Zeitschriftenheftes oder des Kapitels: | 8 | ||||||
| Seitenbereich: | S. 1963-1967 | ||||||
| Datum | August 2006 | ||||||
| Institutionen | Medizin > Lehrstuhl für Innere Medizin II Medizin > Lehrstuhl für Pathologie | ||||||
| Identifikationsnummer |
| ||||||
| Stichwörter / Keywords | RENAL-TRANSPLANT RECIPIENTS; ALLOGRAFT-REJECTION; CYCLOSPORINE-A; CLINICAL-SIGNIFICANCE; EVEROLIMUS; EFFICACY; NEPHROTOXICITY; SAFETY; MULTICENTER; PREVENTION; calcineurin inhibitor toxicity; Doppler sonography; histology; immunosuppression; kidney transplantation; renal failure | ||||||
| Dewey-Dezimal-Klassifikation | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin | ||||||
| Status | Veröffentlicht | ||||||
| Begutachtet | Ja, diese Version wurde begutachtet | ||||||
| An der Universität Regensburg entstanden | Ja | ||||||
| Dokumenten-ID | 1316 |
Downloadstatistik
Downloadstatistik